CLINICAL CASE: EVALUATION OF RETINAL NEOVASCULARIZATION CHANGES ON OCTA AFTER INTRAVITREAL BEVACIZUMAB INJECTION FOR PROLIFERATIVE DIABETIC RETINOPATHY
Main Article Content
Abstract
In the era of non-invasive imaging, OCTA has emerged as a modern tool for monitoring the therapeutic response of retinal neovascularization following anti-VEGF injection. We report a case of a 40-year-old male patient with type 2 diabetes, diagnosed with proliferative diabetic retinopathy, who was treated with three consecutive intravitreal injections of Bevacizumab. Through OCTA follow-up and ETDRS grid analysis, we recorded an improvement in visual acuity along with a marked reduction in neovascular area, vessel density, and perfusion density after each injection. The clinical outcomes highlight the practical role of OCTA in evaluating treatment response and guiding timely therapeutic adjustments.
Article Details
Keywords
Proliferative diabetic retinalpathy, intravitreal Bevacizuman Injection, OCT Angiography
References
2. Arevalo JF, et al. Intravitreal Bevacizumab for proliferative diabetic retinopathy: results from the Pan-American Collaborative Retina Study Group (PACORES). Br J Ophthalmol. 2008;92(5): 630–635.
3. Ishibazawa A, et al. Optical coherence tomography angiography in diabetic retinopathy: a prospective pilot study. Am J Ophthalmol. 2015;160(1):35–44.
4. Couturier A, et al. Capillary plexus anomalies in diabetic retinopathy on optical coherence tomography angiography. Retina. 2015;35(11): 2384–2391.
5. You Q, et al. Detection of new vessels on optical coherence tomography angiography in eyes with diabetic retinopathy. Ophthalmology Retina. 2018;2(9): 775–783.
6. de Carlo TE, et al. Retinal microvasculature abnormalities in proliferative diabetic retinopathy on OCT angiography. Ophthalmic Surg Lasers Imaging Retina. 2016;47(7): 593–600.
7. Hwang TS, et al. Optical coherence tomography angiography features of diabetic retinopathy and their association with visual acuity. Ophthalmology. 2021;128(6):765–776.